Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma

NCT00080886 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: carmustine
DRUG: cytarabine
DRUG: etoposide
DRUG: melphalan
PROCEDURE: autologous bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

University of Nebraska

Collaborators

[object Object]